In a groundbreaking development in the field of neurotechnology, Exclusive-Synchron, a competitor to Elon Musk's Neuralink, is gearing up to conduct a significant trial involving brain implants.
The trial, which has received approval from the Food and Drug Administration (FDA), marks a significant milestone in the company's efforts to advance brain-computer interface technology.